The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a ...

(Reuters) -The U.S. Food and Drug Administration said on Friday that it had eliminated the risk evaluation and mitigation ...

The agency will allow BMS to discontinue REMS programs for both therapies and reduce certain patient monitoring requirements.

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell ...

The agency removed some onerous requirements for the complex cancer drugs and reduced restrictions on patients’ ...

Label changes remove Risk Evaluation and Mitigation Strategy programs and eases monitoring requirements, supporting broader ...

Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and ...

FDA updates CAR T-cell therapy labels for liso-cel and ide-cel, easing monitoring requirements and expanding access for ...

Bristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has given approval to label updates ...

Bristol police arrested and cited Timothy Taylor, 59, of Bristol following a June 6 traffic stop on Sugar Maple Lane, during which police determined Taylor had two active warrants and was driving ...

One of the founders of Spire Motorsports has entered an agreement to purchase the NASCAR team owned by Rick Ware and is ...

NASCAR driver Ricky Stenhouse Jr. advises the Cincinnati Reds and Atlanta Braves to watch a couple of night races at Bristol ...